Literature DB >> 22415264

Kinetoplastid membrane protein-11 exacerbates infection with Leishmania amazonensis in murine macrophages.

Daniel Ignacchiti Lacerda1, Léa Cysne-Finkelstein, Marise Pinheiro Nunes, Paula Mello De-Luca, Marcelo da Silva Genestra, Leonor Laura Pinto Leon, Marcia Berrêdo-Pinho, Leila Mendonça-Lima, Denise Cristina de Souza Matos, Marco Alberto Medeiros, Sergio Coutinho Furtado de Mendonça.   

Abstract

In Leishmania amazonensis, kinetoplastid membrane protein-11 (KMP-11) expression increases during meta-cyclogenesis and is higher in amastigotes than in promastigotes, suggesting a role for this protein in the infection of the mammalian host. We show that the addition of KMP-11 exacerbates L. amazonensis infection in peritoneal macrophages from BALB/c mice by increasing interleukin (IL)-10 secretion and arginase activity while reducing nitric oxide (NO) production. The doses of KMP-11, the IL-10 levels and the intracellular amastigote loads were strongly, positively and significantly correlated. The increase in parasite load induced by KMP-11 was inhibited by anti-KMP-11 or anti-IL-10 neutralising antibodies, but not by isotype controls. The neutralising antibodies, but not the isotype controls, were also able to significantly decrease the parasite load in macrophages cultured without the addition of KMP-11, demonstrating that KMP-11-induced exacerbation of the infection is not dependent on the addition of exogenous KMP-11 and that the protein naturally expressed by the parasite is able to promote it. In this study, the exacerbating effect of KMP-11 on macrophage infection with Leishmania is for the first time demonstrated, implicating it as a virulence factor in L. amazonensis. The stimulation of IL-10 production and arginase activity and the inhibition of NO synthesis are likely involved in this effect.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22415264     DOI: 10.1590/s0074-02762012000200014

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  11 in total

1.  Enhancement of experimental cutaneous leishmaniasis by Leishmania extract: identification of a disease-associated antibody specificity.

Authors:  Virgínia M G Silva; Cíntia F de-Araújo; Isabela C Navarro; Pablo R S Oliveira; Lain Pontes-de-Carvalho
Journal:  BMC Res Notes       Date:  2015-05-14

2.  HisAK70: progress towards a vaccine against different forms of leishmaniosis.

Authors:  Gustavo Domínguez-Bernal; Pilar Horcajo; José A Orden; José A Ruiz-Santa-Quiteria; Ricardo De La Fuente; Lara Ordóñez-Gutiérrez; Abel Martínez-Rodrigo; Alicia Mas; Javier Carrión
Journal:  Parasit Vectors       Date:  2015-12-09       Impact factor: 3.876

3.  Leishmania braziliensis and Leishmania amazonensis amastigote extracts differ in their enhancement effect on Leishmania infection when injected intradermally.

Authors:  Cintia F de Araújo; Virgínia M G Silva; Andre Cronemberger-Andrade; Luciana S Aragão-França; Viviane C J Rocha; Priscila S L Santos; Lain Pontes-de-Carvalho
Journal:  BMC Res Notes       Date:  2014-02-01

4.  Cyclooxygenase-2 in tumor-associated macrophages promotes breast cancer cell survival by triggering a positive-feedback loop between macrophages and cancer cells.

Authors:  Hongzhong Li; Bing Yang; Jing Huang; Yong Lin; Tingxiu Xiang; Jingyuan Wan; Hongyuan Li; Salem Chouaib; Guosheng Ren
Journal:  Oncotarget       Date:  2015-10-06

5.  Resolvin D1 drives establishment of Leishmania amazonensis infection.

Authors:  Hayna Malta-Santos; Bruno B Andrade; Dalila L Zanette; Jackson M Costa; Patrícia T Bozza; Christianne Bandeira-Melo; Aldina Barral; Jaqueline França-Costa; Valéria M Borges
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

6.  Immunomodulation in human dendritic cells leads to induction of interferon-gamma production by Leishmania donovani derived KMP-11 antigen via activation of NF-κB in Indian kala-azar patients.

Authors:  Rajesh Chaudhary; Ajay Amit; Anupam Yadav; Anurag Singh; Vikash Kumar; S K Singh; Shyam Narayan; Vidyanand Rabidas; K Pandey; Anil Kumar; Pradeep Das; Sanjiva Bimal
Journal:  Biomed Res Int       Date:  2014-01-22       Impact factor: 3.411

Review 7.  Cutaneous Leishmaniasis Vaccination: A Matter of Quality.

Authors:  Paula Mello De Luca; Amanda Beatriz Barreto Macedo
Journal:  Front Immunol       Date:  2016-04-21       Impact factor: 7.561

Review 8.  Kinetoplastid Membrane Protein-11 as a Vaccine Candidate and a Virulence Factor in Leishmania.

Authors:  Sergio Coutinho Furtado de Mendonça; Léa Cysne-Finkelstein; Denise Cristina de Souza Matos
Journal:  Front Immunol       Date:  2015-10-13       Impact factor: 7.561

Review 9.  Differences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discovery.

Authors:  Sergio C F Mendonça
Journal:  Parasit Vectors       Date:  2016-09-06       Impact factor: 3.876

Review 10.  Leishmania Hijacks Myeloid Cells for Immune Escape.

Authors:  María Martínez-López; Manuel Soto; Salvador Iborra; David Sancho
Journal:  Front Microbiol       Date:  2018-05-07       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.